MedTrace Logo

Dual-chamber Patient-controlled Analgesia for Postoperative Recovery

NCT07051109 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2025-07-03

No results posted yet for this study

Summary

Postoperative nausea and vomiting (PONV) are the most common complications that can occur after general anesthesia. Postoperative use of opioids and morbid obesity have been reported as risk factors of PONV. In this study, the investigators aimed to compare the degree of postoperative side effects and pain control when an intravenous patient-controlled analgesia combining fentanyl and ketorolac via a dual-chamber device was provided to participants undergoing laparoscopic sleeve gastrectomy.

Conditions

  • Morbid Obesity
  • PCA
  • Analgesia
  • PONV

Interventions

DEVICE

multimodal analgesia via dual-chamber PCA

combination of fentanyl and ketorolac through dual-chamber PCA

DEVICE

single regimen (only fentanyl)

fentanyl only through dual-chamber PCA

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-11
Primary Completion
2025-08-11
Completion
2026-03-11

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07051109 on ClinicalTrials.gov